{"transactions":[{"id":729585,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:56:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":18880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18880},"source":{"system":"sec-edgar","filing":"0001104659-26-076927","document":"tm2618639-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076927/tm2618639-6_4seq1.xml","form_type":"4"}},{"id":729584,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T23:56:21.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":14180,"derivative":{"underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001104659-26-076927","document":"tm2618639-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076927/tm2618639-6_4seq1.xml","form_type":"4"}},{"id":729583,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T23:56:21.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":21270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":21270,"derivative":{"exercise_price":9.13,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":21270},"source":{"system":"sec-edgar","filing":"0001104659-26-076927","document":"tm2618639-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076927/tm2618639-6_4seq1.xml","form_type":"4"}},{"id":729582,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T23:56:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":18880,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":73220,"source":{"system":"sec-edgar","filing":"0001104659-26-076927","document":"tm2618639-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926076927/tm2618639-6_4seq1.xml","form_type":"4"}},{"id":731039,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-22T20:26:42.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":49579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":49579,"derivative":{"exercise_price":1.13,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":49579},"source":{"system":"sec-edgar","filing":"0000905148-26-003053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000090514826003053/form4.xml","form_type":"4"}},{"id":731038,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T20:26:42.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 17, 2027, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":260998,"source":{"system":"sec-edgar","filing":"0000905148-26-003053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000090514826003053/form4.xml","form_type":"4"}},{"id":742201,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:26:17.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":2323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":2323,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":2323},"source":{"system":"sec-edgar","filing":"0001193125-26-267629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000119312526267629/ownership.xml","form_type":"4"}},{"id":742200,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:26:17.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":19909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":19909,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":19909},"source":{"system":"sec-edgar","filing":"0001193125-26-267629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000119312526267629/ownership.xml","form_type":"4"}},{"id":742199,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:26:17.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001193125-26-267629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000119312526267629/ownership.xml","form_type":"4"}},{"id":832743,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T20:17:41.000Z","date":"2026-03-19","kind":"purchase","planned":false,"acquired":true,"shares":70000,"price":1.4,"value":98000.0,"ownership":{"direct":true},"balance_after":195000,"source":{"system":"sec-edgar","filing":"0001193125-26-117675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000119312526117675/ownership.xml","form_type":"4"}},{"id":1068159,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-13T23:46:18.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":80000,"price":1.388,"value":111040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":230577,"source":{"system":"sec-edgar","filing":"0000905148-25-002874","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000090514825002874/form4.xml","form_type":"4"}},{"id":1103161,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:37:53.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":18884,"derivative":{"underlying":"Common Stock","underlying_shares":18884},"source":{"system":"sec-edgar","filing":"0001104659-25-062193","document":"tm2518838-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062193/tm2518838-3_4seq1.xml","form_type":"4"}},{"id":1103160,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:37:53.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":28326,"price":6.42,"value":181852.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 20, 2024 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":28326,"derivative":{"exercise_price":6.42,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":28326},"source":{"system":"sec-edgar","filing":"0001104659-25-062193","document":"tm2518838-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925062193/tm2518838-3_4seq1.xml","form_type":"4"}},{"id":1104241,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-23T22:39:57.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50790,"derivative":{"exercise_price":2.11,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":50790},"source":{"system":"sec-edgar","filing":"0000905148-25-002232","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000090514825002232/form4.xml","form_type":"4"}},{"id":1104240,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-23T22:39:57.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":29210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 18, 2026, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":150577,"source":{"system":"sec-edgar","filing":"0000905148-25-002232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000090514825002232/form4.xml","form_type":"4"}},{"id":1112399,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-14T01:36:23.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-25-000757","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000757/primary_01.xml","form_type":"4"}},{"id":1112398,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T01:36:23.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54340,"source":{"system":"sec-edgar","filing":"0001593968-25-000757","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000757/primary_01.xml","form_type":"4"}},{"id":1114109,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:27:13.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":1689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1689,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":1689},"source":{"system":"sec-edgar","filing":"0000950170-25-085441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017025085441/ownership.xml","form_type":"4"}},{"id":1114108,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:27:13.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":14476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":14476,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":14476},"source":{"system":"sec-edgar","filing":"0000950170-25-085441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017025085441/ownership.xml","form_type":"4"}},{"id":1114107,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:27:13.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":62728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":62728,"derivative":{"exercise_price":2.685,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":62728},"source":{"system":"sec-edgar","filing":"0000950170-25-085441","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017025085441/ownership.xml","form_type":"4"}},{"id":1479729,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:10:42.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10420,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10420,"derivative":{"exercise_price":0,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0001593968-24-000863","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000863/primary_01.xml","form_type":"4"}},{"id":1479728,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:10:42.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":15.86,"value":247891.8,"ownership":{"direct":true},"balance_after":15630,"derivative":{"exercise_price":15.86,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0001593968-24-000863","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000863/primary_01.xml","form_type":"4"}},{"id":1479727,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-06-14T20:10:42.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":false,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001593968-24-000863","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000863/primary_01.xml","form_type":"4"}},{"id":1479726,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:10:42.000Z","date":"2024-06-12","kind":"exercise","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43920,"source":{"system":"sec-edgar","filing":"0001593968-24-000863","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000863/primary_01.xml","form_type":"4"}},{"id":1481227,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T21:39:41.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":40701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":40701,"derivative":{"exercise_price":4.68,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":40701},"source":{"system":"sec-edgar","filing":"0001415889-24-016715","document":"form4-06132024_090638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000141588924016715/form4-06132024_090638.xml","form_type":"4"}},{"id":1481226,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T21:39:41.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":21367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"This annual grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this grant vest on June 11, 2025, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":121367,"source":{"system":"sec-edgar","filing":"0001415889-24-016715","document":"form4-06132024_090638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000141588924016715/form4-06132024_090638.xml","form_type":"4"}},{"id":1488881,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:15:15.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":1215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1215,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":1215},"source":{"system":"sec-edgar","filing":"0000950170-24-069900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017024069900/ownership.xml","form_type":"4"}},{"id":1488880,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:15:15.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":10418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":10418,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":10418},"source":{"system":"sec-edgar","filing":"0000950170-24-069900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017024069900/ownership.xml","form_type":"4"}},{"id":1488879,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:15:15.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":40282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":40282,"derivative":{"exercise_price":4.09,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":40282},"source":{"system":"sec-edgar","filing":"0000950170-24-069900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017024069900/ownership.xml","form_type":"4"}},{"id":1837537,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:32:08.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":640,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":640},"source":{"system":"sec-edgar","filing":"0000950170-23-031778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017023031778/ownership.xml","form_type":"4"}},{"id":1837536,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:32:08.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":5488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":5488,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":5488},"source":{"system":"sec-edgar","filing":"0000950170-23-031778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017023031778/ownership.xml","form_type":"4"}},{"id":1837535,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-05T21:32:08.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":21222,"derivative":{"exercise_price":8.39,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":21222},"source":{"system":"sec-edgar","filing":"0000950170-23-031778","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000095017023031778/ownership.xml","form_type":"4"}},{"id":1845676,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T21:34:29.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 22, 2024, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.57,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-039477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000120919123039477/doc4.xml","form_type":"4"}},{"id":1857750,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:44:33.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":6670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6670,"derivative":{"underlying":"Common Stock","underlying_shares":6670},"source":{"system":"sec-edgar","filing":"0001209191-23-036744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036744/doc4.xml","form_type":"4"}},{"id":1857749,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-13T20:44:33.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":7710,"derivative":{"exercise_price":7.78,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":7710},"source":{"system":"sec-edgar","filing":"0001209191-23-036744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036744/doc4.xml","form_type":"4"}},{"id":1857748,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T20:44:33.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":false,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-23-036744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036744/doc4.xml","form_type":"4"}},{"id":1857747,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T20:44:33.000Z","date":"2023-06-10","kind":"exercise","planned":false,"acquired":true,"shares":3100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":37250,"source":{"system":"sec-edgar","filing":"0001209191-23-036744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123036744/doc4.xml","form_type":"4"}},{"id":1935196,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-30T13:11:05.000Z","date":"2023-03-29","kind":"purchase","planned":false,"acquired":true,"shares":80000,"price":4.3185,"value":345480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-23-021573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000120919123021573/doc4.xml","form_type":"4"}},{"id":2210199,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-08T20:05:40.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":26900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual option grant was made pursuant to the Issuer's Equity Grant Policy for non-employee directors. The shares underlying this option vest on June 29, 2023, subject to the reporting person's continuous service as of such vesting date."}],"balance_after":26900,"derivative":{"exercise_price":4.82,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":26900},"source":{"system":"sec-edgar","filing":"0001209191-22-041612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000120919122041612/doc4.xml","form_type":"4"}},{"id":2226048,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:46:02.000Z","date":"2022-06-17","kind":"exercise","acquired":false,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 17, 2021 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-22-038592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038592/doc4.xml","form_type":"4"}},{"id":2226047,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:46:02.000Z","date":"2022-06-17","kind":"exercise","acquired":true,"shares":700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":34150,"source":{"system":"sec-edgar","filing":"0001209191-22-038592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122038592/doc4.xml","form_type":"4"}},{"id":2233196,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-14T21:07:38.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":3100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":3100,"derivative":{"underlying":"Common Stock","underlying_shares":3100},"source":{"system":"sec-edgar","filing":"0001209191-22-036749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036749/doc4.xml","form_type":"4"}},{"id":2233195,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T21:07:38.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 10, 2022 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":4600,"derivative":{"exercise_price":40.62,"exercise_date":"2023-06-10","expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001209191-22-036749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122036749/doc4.xml","form_type":"4"}},{"id":2238191,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1624,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0000899243-22-021633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924322021633/doc4.xml","form_type":"4"}},{"id":2238190,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":13917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":13917,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":13917},"source":{"system":"sec-edgar","filing":"0000899243-22-021633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924322021633/doc4.xml","form_type":"4"}},{"id":2238189,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:06:09.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":53812,"derivative":{"exercise_price":3.6,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":53812},"source":{"system":"sec-edgar","filing":"0000899243-22-021633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924322021633/doc4.xml","form_type":"4"}},{"id":2472200,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-15T22:22:38.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.6,"exercise_date":"2012-09-01","expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-21-069798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121069798/doc4.xml","form_type":"4"}},{"id":2472199,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-15T22:22:38.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":1500,"price":25.6,"value":38400.0,"ownership":{"direct":true},"balance_after":33450,"source":{"system":"sec-edgar","filing":"0001209191-21-069798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121069798/doc4.xml","form_type":"4"}},{"id":2499241,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T12:46:26.000Z","date":"2021-11-22","kind":"purchase","acquired":true,"shares":20000,"price":11.12,"value":222400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the securities on the open market at purchase prices ranging from $11.01 to $11.16 per share, with a weighted average purchase price of $11.12 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-066289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000120919121066289/doc4.xml","form_type":"4"}},{"id":2607433,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T21:13:14.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000120919121050931/doc4.xml","form_type":"4"}},{"id":2652457,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-29T21:13:04.000Z","date":"2021-06-25","kind":"exercise","acquired":false,"shares":3450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 25, 2020 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3450},"source":{"system":"sec-edgar","filing":"0001209191-21-043700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121043700/doc4.xml","form_type":"4"}},{"id":2652456,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-29T21:13:04.000Z","date":"2021-06-25","kind":"exercise","acquired":true,"shares":3450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":31950,"source":{"system":"sec-edgar","filing":"0001209191-21-043700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121043700/doc4.xml","form_type":"4"}},{"id":2659492,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-22T21:16:10.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":700,"derivative":{"underlying":"Common Stock","underlying_shares":700},"source":{"system":"sec-edgar","filing":"0001209191-21-042451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042451/doc4.xml","form_type":"4"}},{"id":2659491,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:16:10.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\") will vest one (1) year from the June 17, 2021 grant date (the \"Grant Date\") subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":1300,"derivative":{"exercise_price":179.89,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":1300},"source":{"system":"sec-edgar","filing":"0001209191-21-042451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121042451/doc4.xml","form_type":"4"}},{"id":2674478,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":408,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":408},"source":{"system":"sec-edgar","filing":"0000899243-21-023013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924321023013/doc4.xml","form_type":"4"}},{"id":2674477,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":3500,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000899243-21-023013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924321023013/doc4.xml","form_type":"4"}},{"id":2674476,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-10T21:46:58.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":13534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":13534,"derivative":{"exercise_price":12.97,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":13534},"source":{"system":"sec-edgar","filing":"0000899243-21-023013","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924321023013/doc4.xml","form_type":"4"}},{"id":2922573,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:42:52.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":50,"exercise_date":"2011-09-10","expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001209191-21-001404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001404/doc4.xml","form_type":"4"}},{"id":2922572,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:42:52.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":1000,"price":50,"value":50000.0,"ownership":{"direct":true},"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001209191-21-001404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121001404/doc4.xml","form_type":"4"}},{"id":3099301,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-27T01:16:04.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":3450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":3450,"derivative":{"underlying":"Common Stock","underlying_shares":3450},"source":{"system":"sec-edgar","filing":"0001209191-20-039191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120039191/doc4.xml","form_type":"4"}},{"id":3099300,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-06-27T01:16:04.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest one (1) year from the June 25, 2020 grant date (the \"Grant Date\"), subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":6900,"derivative":{"exercise_price":83.54,"exercise_date":"2021-06-25","expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":6900},"source":{"system":"sec-edgar","filing":"0001209191-20-039191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919120039191/doc4.xml","form_type":"4"}},{"id":3113837,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:48:30.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1079,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":1079},"source":{"system":"sec-edgar","filing":"0000899243-20-016182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924320016182/doc4.xml","form_type":"4"}},{"id":3113836,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:48:30.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":9245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":9245,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":9245},"source":{"system":"sec-edgar","filing":"0000899243-20-016182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924320016182/doc4.xml","form_type":"4"}},{"id":3113835,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T21:48:30.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":26503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":26503,"derivative":{"exercise_price":5.02,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":26503},"source":{"system":"sec-edgar","filing":"0000899243-20-016182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924320016182/doc4.xml","form_type":"4"}},{"id":3206719,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T20:38:45.000Z","date":"2020-03-16","kind":"purchase","acquired":true,"shares":40000,"price":2.75,"value":110000.0,"ownership":{"direct":true},"balance_after":125000,"source":{"system":"sec-edgar","filing":"0000899243-20-008616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924320008616/doc4.xml","form_type":"4"}},{"id":3341389,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-12-16T21:58:03.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 12, 2019 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":18000,"derivative":{"exercise_price":3.99,"exercise_date":"2020-12-12","expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-19-060685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919119060685/doc4.xml","form_type":"4"}},{"id":3413021,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-17T11:36:42.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":5000,"price":6,"value":30000.0,"ownership":{"direct":true},"balance_after":85000,"source":{"system":"sec-edgar","filing":"0000899243-19-023719","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319023719/doc4.xml","form_type":"4"}},{"id":3415313,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-13T11:54:31.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":10000,"price":6.0276,"value":60276.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.93 to $6.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0000899243-19-023539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319023539/doc4.xml","form_type":"4"}},{"id":3415312,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-13T11:54:31.000Z","date":"2019-09-11","kind":"purchase","acquired":true,"shares":10000,"price":5.7529,"value":57529.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.65 to $5.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0000899243-19-023539","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319023539/doc4.xml","form_type":"4"}},{"id":3417928,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-11T20:05:27.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":10000,"price":5.0857,"value":50857.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0000899243-19-023315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319023315/doc4.xml","form_type":"4"}},{"id":3417927,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-11T20:05:27.000Z","date":"2019-09-09","kind":"purchase","acquired":true,"shares":10000,"price":4.9106,"value":49106.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.82 to $4.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000899243-19-023315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319023315/doc4.xml","form_type":"4"}},{"id":3499328,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:36:02.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":771,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0000899243-19-015821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319015821/doc4.xml","form_type":"4"}},{"id":3499327,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:36:02.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":6611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":6611,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":6611},"source":{"system":"sec-edgar","filing":"0000899243-19-015821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319015821/doc4.xml","form_type":"4"}},{"id":3499326,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-06T21:36:02.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":18951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":18951,"derivative":{"exercise_price":7.06,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":18951},"source":{"system":"sec-edgar","filing":"0000899243-19-015821","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924319015821/doc4.xml","form_type":"4"}},{"id":3731239,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2018-12-14T21:48:24.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 13, 2018 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":90000,"derivative":{"exercise_price":2.3,"exercise_date":"2019-12-13","expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-18-062750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919118062750/doc4.xml","form_type":"4"}},{"id":3900519,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:37:44.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":632,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":632},"source":{"system":"sec-edgar","filing":"0000899243-18-015770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924318015770/doc4.xml","form_type":"4"}},{"id":3900518,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:37:44.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":5416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":5416,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":5416},"source":{"system":"sec-edgar","filing":"0000899243-18-015770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924318015770/doc4.xml","form_type":"4"}},{"id":3900517,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T20:37:44.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":15526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":15526,"derivative":{"exercise_price":8.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":15526},"source":{"system":"sec-edgar","filing":"0000899243-18-015770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924318015770/doc4.xml","form_type":"4"}},{"id":4127158,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-12-19T21:11:15.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 15, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":80000,"derivative":{"exercise_price":1.38,"exercise_date":"2018-12-15","expiration_date":"2027-12-15","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-17-066314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117066314/doc4.xml","form_type":"4"}},{"id":4285993,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:05:42.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":1037,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":1037},"source":{"system":"sec-edgar","filing":"0000899243-17-016102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924317016102/doc4.xml","form_type":"4"}},{"id":4285992,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:05:42.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":8888,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0000899243-17-016102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924317016102/doc4.xml","form_type":"4"}},{"id":4285991,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-12T21:05:42.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17776,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date."}],"balance_after":17776,"derivative":{"exercise_price":5.15,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":17776},"source":{"system":"sec-edgar","filing":"0000899243-17-016102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924317016102/doc4.xml","form_type":"4"}},{"id":4323431,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-12T13:59:10.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":200000,"price":0.9289,"value":185780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9049 to $0.94, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":550000,"source":{"system":"sec-edgar","filing":"0001209191-17-031713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117031713/doc4.xml","form_type":"4"}},{"id":4378473,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-03-20T20:17:00.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan will vest one (1) year from the March 16, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date."}],"balance_after":80000,"derivative":{"exercise_price":1.38,"exercise_date":"2018-03-16","expiration_date":"2027-03-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-17-021709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919117021709/doc4.xml","form_type":"4"}},{"id":4436988,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-21T21:33:12.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":40000,"price":4.5,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000899243-17-004755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924317004755/doc4.xml","form_type":"4"}},{"id":4597425,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-22T20:26:09.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":100000,"price":1.7201,"value":172010.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.715 to $1.73, inclusive. The reporting person undertakes to provide Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":350000,"source":{"system":"sec-edgar","filing":"0001209191-16-142465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919116142465/doc4.xml","form_type":"4"}},{"id":4603487,"issuer":{"id":6839,"kind":"organization","name":"Aldeyra Therapeutics, Inc."},"owners":[{"id":36117,"kind":"person","name":"DOUGLAS RICHARD","position":1,"cik":"0001021015","reported_name":"DOUGLAS RICHARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-09-14T20:45:32.000Z","date":"2016-09-13","kind":"grant","acquired":true,"shares":12166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable in equal annual installments over three years of continuous service to the Issuer after September 13, 2016."}],"balance_after":12166,"derivative":{"exercise_price":5.62,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":12166},"source":{"system":"sec-edgar","filing":"0000899243-16-028966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1021015/000089924316028966/doc4.xml","form_type":"4"}}]}